According to a recently published report, the Glucosamine market is expected to grow at the CAGR of 14.3% during 2015-2022 and it estimated to be $1.2 billion by 2022. The global glucosamine market is segmented on the basis of industry applications and geography. The report on global glucosamine market forecast 2015-2022 provides detailed overview and predictive analysis of the market.
The global glucosamine market is expected to grow exponentially due to huge adoption of applications in the healthcare sector. The increasing demand for glucosamine products due to rising arthritis and increase in vegan population are the major driver for the adoption of glucosamine products. Glucosamine products enable the patient to overcome arthritis disease and also the awareness among young individuals enables the glucosamine market to grow fast.
Full report available global glucosamine market forecast 2015-2022 report at http://briskinsights.com/report/global-glucosamine-market-forecast-2015-2022
Glucosamine products provide alterative products to the vegans and enable the arthritis patients to overcome the joint pains and also strengthen the cartilages. The global rise in aging population is expected to create huge demand for glucosamine market. The new products of glucosamine are safe and effective and would bolster lifestyle of the arthritis patients. Alcan chemical division, Alfa chem, Cargill Inc, ethical naturals, Dee pharmaceuticals, golden-shell biochemical co. ltd, Koyo chemical company ltd, Nutramax, Navamedic, Nutrilite are the leading companies in the global glucosamine market.
The major players profiled in the report include Stratasys Ltd., Alcan chemical division, Alfa Chem, Cargill Inc, ethical naturals, and so on. Innovation and R&D are the key winning strategy of the market.
SCOPE OF THE REPORT
1. Global Glucosamine industry market by application 2012-2022
1.1. Nutritional supplement
1.2. Glucosamine demand in supplement
1.3. Food and beverages
1.4. Dairy product
2. Global Glucosamine industry regional outlook 2012-2022 ($ billion)
2.1. North America
2.3. Asia Pacific
2.4. Middle East & Africa
2.5. Central & South America
3. Competitive landscape
3.1. Alcan chemical division
3.2. Alfa chem.
3.3. Cargill Inc
3.4. Ethical naturals
3.5. Dee pharmaceuticals
3.6. Golden-shell biochemical co. ltd
3.7. Koyo chemical company ltd
3.11. Promax nutrition care
3.12. Simply supplements
3.13. Schiff nutrition international Inc
3.14. Synasia Inc
3.15. Thiarco industries Inc
3.16. Xiamen Blue Bay Science & Technology co. ltd
Release ID: 865